Inhibition of the interaction of CD44 with E-selectin by GMI-1271, an E-selectin inhibitor, in combination with imatinib led to greater elimination of LSCs in a murine model of CML. Here, SELE is linked to chronic myelogenous leukemia, BCR-ABL1 positive.